- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- January 2025
- 250 Pages
Global
From €4550EUR$4,999USD£3,900GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1365EUR$1,500USD£1,170GBP
Trimethadione is a Central Nervous System (CNS) drug used to treat certain types of seizures. It is an anticonvulsant that works by decreasing the activity of nerve cells in the brain. Trimethadione is used to treat petit mal seizures, a type of seizure that causes brief lapses in consciousness. It is also used to treat other types of seizures, such as myoclonic seizures and tonic-clonic seizures. Trimethadione is available in tablet form and is usually taken twice a day.
Trimethadione is a relatively uncommon drug, and is not widely prescribed. It is not recommended for use in children, as it can cause serious side effects. Common side effects of trimethadione include drowsiness, dizziness, nausea, and vomiting. More serious side effects can include liver damage, low blood pressure, and anemia.
Trimethadione is manufactured by several companies, including Mylan Pharmaceuticals, Teva Pharmaceuticals, and Sandoz Pharmaceuticals. It is also available as a generic drug. Show Less Read more